Follow The Filings

ADCT position history

The shares of Adc Therapeutics (ADCT) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, SHS

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q3: 682,529 shares, $2.7M, 0.39% of portfolio, New
  2. 2025 Q4: not held, Exit
  3. 2026 Q1: not held
  4. 2026 Q2: 700,000 shares, $749K, 0.07% of portfolio, New
  5. 2026 Q3: 4,070,819 shares, $5M, 0.56% of portfolio, Add +481.5%
Holdings date Value % of holdings Shares Filing date All 13F holders